VIDO-InterVac provides services to groups developing vaccines, antivirals, and therapeutics against COVID-19. This includes:
In vitro testing:
Assess antiviral and/or viral neutralization effect of compounds against SARS-CoV-2.
In vivo testing:
Use our established SARS-CoV-2 challenge models in ferrets and hamsters to test the efficacy of vaccines, antivrials and other therapeutics.
VIDO-InterVac operates with a certified ISO 9001 quality management system. COVID-19 projects are managed by a dedicated project manager and are completed by our multidisciplinary research team in our containment level 3 facility.
Contract us to help with your preclinical development:Contact Us